<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23780" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Islets of Langerhans</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shahid</surname>
            <given-names>Zainab</given-names>
          </name>
          <aff>Lake Erie College of Osteopathic Med.</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Gurdeep</given-names>
          </name>
          <aff>Our Lady of Lourdes Memorial Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zainab Shahid declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gurdeep Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23780.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The islets of Langerhans are clusters of pancreatic cells discovered by Dr. Paul Langerhans, a pathologist who also discovered the dendritic Langerhans cells in 1869.<xref ref-type="bibr" rid="article-23780.r1">[1]</xref> Each islet contains up to a few thousand endocrine cells, and the islets constitute up to 2% of the total pancreatic mass. The islet cells include the alpha cells, beta cells, delta cells, epsilon cells, and pancreatic polypeptide (PP) cells, and each cell releases a specific hormone in response to signals.<xref ref-type="bibr" rid="article-23780.r2">[2]</xref></p>
      </sec>
      <sec id="article-23780.s2" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>Each islet comprises a central core of beta cells, surrounded by a mantle of alpha, delta, epsilon, and pancreatic polypeptide cells. Although most islets follow this "mantle-core" pattern, there are variations amongst islets of different sizes. In general, beta cells comprise up to 60% of islet mass. Alpha cells comprise up to 30% of islet mass; delta, epsilon, and pancreatic polypeptide cells comprise 10%. The blood supply and innervation for each islet are provided by a neurovascular bundle&#x000a0;that penetrates the islet through the central core of beta cells.<xref ref-type="bibr" rid="article-23780.r3">[3]</xref></p>
      </sec>
      <sec id="article-23780.s3" sec-type="Development">
        <title>Development</title>
        <p>The pancreas derives from a dorsal and a ventral bud, both arising from the foregut endoderm and fusing during embryogenesis to form the exocrine and endocrine pancreas. The endocrine pancreas begins forming at ten weeks of gestation by single immature epithelial duct cells, multiplying and forming small islands of cells. These islands are vascularized by 16 weeks of gestation and become encapsulated by connective tissue at this time. The cells eventually differentiate to contain only a single pancreatic hormone, each during the second half of gestation.<xref ref-type="bibr" rid="article-23780.r4">[4]</xref></p>
      </sec>
      <sec id="article-23780.s4" sec-type="Function">
        <title>Function</title>
        <p>Each pancreatic endocrine cell releases&#x000a0;1 specific hormone. The alpha cells release glucagon, a peptide hormone that raises the concentration of glucose and fatty acids in the bloodstream and is the primary catabolic hormone in the body. The beta cells release insulin, a peptide hormone that decreases glucose concentration in the blood by stimulating glucose uptake by the liver, skeletal muscle, and adipose tissue via specialized receptors. The delta cells release somatostatin, which inhibits glucagon and insulin secretion. The epsilon cells release ghrelin, a hormone that stimulates appetite, increases fat storage, and stimulates the growth hormone release from the pituitary gland. The PP cells release pancreatic polypeptide, a satiety hormone that decreases gastric acid secretion, emptying, and upper intestinal motility. These cells communicate through extracellular spaces and gap junctions and influence each other's release of hormones. For example, glucagon release by alpha cells suppresses insulin release by beta cells and vice versa, and somatostatin release by delta cells inhibits glucagon and insulin secretion by the alpha and beta cells.<xref ref-type="bibr" rid="article-23780.r5">[5]</xref></p>
      </sec>
      <sec id="article-23780.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Dysfunction of the islet cells can lead to pancreatic neuroendocrine tumors. These are rare tumors that account for about 7% of all pancreatic masses. They are generally slow-growing and well-differentiated and can be either functioning or non-functioning. Between 50 and 75% of pancreatic neuroendocrine tumors are nonfunctioning and, therefore, are not associated with hormone-related clinical syndrome.<xref ref-type="bibr" rid="article-23780.r6">[6]</xref> Pancreatic neuroendocrine tumors are not always part of multiple endocrine neoplasia type 1 (MEN1) syndrome.</p>
        <p>Multiple endocrine neoplasia type 1 is a rare endocrine tumor syndrome that can cause insulinomas, glucagonomas, and nonfunctioning tumors of the pancreas, in addition to tumors of the parathyroid and pituitary glands. It occurs due to an inactivating germline mutation in the MEN1 gene on chromosome 11 in most cases, although 20% of patients with the MEN1 syndrome do not have a mutation in this gene. Pancreatic neuroendocrine tumors can occur in 30 to 75% of patients presenting with this syndrome, and nonfunctioning neuroendocrine tumors are more common than functioning ones. A thorough medical and family history is crucial in making an early diagnosis of MEN1, which can be lifesaving as this syndrome is associated with a high mortality rate.<xref ref-type="bibr" rid="article-23780.r7">[7]</xref></p>
        <p>
<bold>Nonfunctional Islet Cell Tumor</bold>
</p>
        <p>Non-functioning tumors represent most pancreatic neuroendocrine tumors, and between 60 and 90% of them are malignant. These tumors may release certain substances, such as pancreatic polypeptide and chromogranin A, which are also useful as tumor markers in patients. They do not present clinically with a hormonal syndrome, which can cause a delay in the diagnosis. More than 50% of these tumors are diagnosed incidentally in asymptomatic patients undergoing diagnostic evaluations for other unrelated conditions.<xref ref-type="bibr" rid="article-23780.r8">[8]</xref> Symptoms due to these tumors are due to mass effect and include abdominal pain, weight loss, anorexia, nausea, obstructive jaundice, intra-abdominal hemorrhage, or a palpable mass.<xref ref-type="bibr" rid="article-23780.r6">[6]</xref></p>
        <p>
<bold>Insulinoma</bold>
</p>
        <p>Insulinomas are the most common functioning tumors composed of pancreatic beta cells. They occur in adults between 31 to 63 years old and have a slight female predominance. Morphologically, they are small tumors, up to 80% of them being less than 2 cm, and are distributed equally throughout the pancreas's head, body, and tail. Although between 5 and 15% of insulinomas can be malignant, most are benign and amenable to surgical excision.<xref ref-type="bibr" rid="article-23780.r6">[6]</xref></p>
        <p>These tumors secrete high amounts of insulin, a hormone that binds to specific receptors in the liver, adipose tissue, and skeletal muscle and causes glucose uptake in these cells. Therefore, the clinical manifestations of insulinomas are related to hypoglycemia. The neuroglycopenic symptoms include weakness, loss of consciousness, and confusion, and the autonomic symptoms include palpitations, tremors, hunger, and sweating. A feared complication is hypoglycemic coma, which can occur suddenly and lead to brain death. The periods of hypoglycemia occur most commonly after fasting or physical exercise but can also occur without any relationship to meal times or exercise. Fasting hypoglycemia with a glucose level of less than 45 mg/dl with concomitant hyperinsulinemia and elevated levels of proinsulin and C-peptide can confirm the diagnosis of insulinoma.<xref ref-type="bibr" rid="article-23780.r9">[9]</xref></p>
        <p>
<bold>Glucagonoma</bold>
</p>
        <p>Glucagonomas are rare tumors, making up 7% of all functioning pancreatic endocrine tumors composed of pancreatic alpha cells. They occur in adults in their fifth decade and are evenly distributed between males and females. Morphologically, they are encapsulated and firm, vary in size from 2 to 25 cm, and occur most commonly in the tail of the pancreas. The majority of these tumors are malignant, and 50 to 80% of patients have metastasis to the liver at the initial presentation.<xref ref-type="bibr" rid="article-23780.r6">[6]</xref></p>
        <p>These tumors secrete high amounts of glucagon, a hormone that increases the blood glucose concentration by converting stored glycogen to glucose within the liver. The clinical manifestations of these tumors are unique. While the most common symptoms are weight loss and necrolytic migratory erythema, patients can also present with cheilitis, diabetes mellitus, anemia, diarrhea, venous thrombosis, and neuropsychiatric symptoms. The rash of necrolytic migratory erythema is often the presenting symptom of an underlying glucagonoma; it begins with erythematous papules and plaques on the face, perineum, and extremities.&#x000a0;These lesions later enlarge, coalesce, and have a central clearing with peripheral crusting and scaling. It is also often associated with intense pruritus and pain.<xref ref-type="bibr" rid="article-23780.r10">[10]</xref></p>
        <p>
<bold>Somatostatinoma</bold>
</p>
        <p>Somatostatinomas are very rare tumors of the pancreatic delta cells, occurring in 1 in 40 million people per year. These tumors can arise in both the pancreas and the duodenum, and the vast majority are malignant. They are most commonly found incidentally as they contain immune-reactive granules but cause no functional syndrome. Symptoms due to somatostatinomas are due to mass effects and include abdominal pain, weight loss, and jaundice.<xref ref-type="bibr" rid="article-23780.r11">[11]</xref></p>
      </sec>
      <sec id="article-23780.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23780&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23780">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23780/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23780">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23780.s7">
        <title>References</title>
        <ref id="article-23780.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jolles</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Paul Langerhans.</article-title>
            <source>J Clin Pathol</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>243</fpage>
            <pub-id pub-id-type="pmid">11919207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ionescu-Tirgoviste</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gagniuc</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Gubceac</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mardare</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Militaru</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A 3D map of the islet routes throughout the healthy human pancreas.</article-title>
            <source>Sci Rep</source>
            <year>2015</year>
            <month>Sep</month>
            <day>29</day>
            <volume>5</volume>
            <fpage>14634</fpage>
            <pub-id pub-id-type="pmid">26417671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonner-Weir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Weir</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Human Islet Morphology Revisited: Human and Rodent Islets Are Not So Different After All.</article-title>
            <source>J Histochem Cytochem</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>63</volume>
            <issue>8</issue>
            <fpage>604</fpage>
            <page-range>604-12</page-range>
            <pub-id pub-id-type="pmid">25604813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fowden</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Intra-uterine programming of the endocrine pancreas.</article-title>
            <source>Br Med Bull</source>
            <year>2001</year>
            <volume>60</volume>
            <fpage>123</fpage>
            <page-range>123-42</page-range>
            <pub-id pub-id-type="pmid">11809622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Da Silva Xavier</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Cells of the Islets of Langerhans.</article-title>
            <source>J Clin Med</source>
            <year>2018</year>
            <month>Mar</month>
            <day>12</day>
            <volume>7</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">29534517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grozinsky-Glasberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mazeh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical features of pancreatic neuroendocrine tumors.</article-title>
            <source>J Hepatobiliary Pancreat Sci</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>578</fpage>
            <page-range>578-85</page-range>
            <pub-id pub-id-type="pmid">25689919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r7">
          <label>7</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Singh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mulji</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Jialal</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <chapter-title>Multiple Endocrine Neoplasia Type 1</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">30725665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorelik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cooperman</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors: Who, When, and How to Treat?</article-title>
            <source>Surg Clin North Am</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>98</volume>
            <issue>1</issue>
            <fpage>157</fpage>
            <page-range>157-167</page-range>
            <pub-id pub-id-type="pmid">29191272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okabayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sumiyoshi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kozuki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanazaki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of insulinoma.</article-title>
            <source>World J Gastroenterol</source>
            <year>2013</year>
            <month>Feb</month>
            <day>14</day>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>829</fpage>
            <page-range>829-37</page-range>
            <pub-id pub-id-type="pmid">23430217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Foss</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Hashmi</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ferrer-Bruker</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <chapter-title>Necrolytic Migratory Erythema</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">30422467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23780.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Somatostatinoma</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">25905263</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
